Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Continues Its Introduction of LACRIFILL^® Canalicular Gel, a Novel Therapy for Dry Eye, During American Academy of Ophthalmology (AAO) 2024

by merzdev | Oct 17, 2024 | News

Nordic Pharma to share this innovation and its pivotal study article in the Journal of Cataract and Refractive Surgery (JCRS) with ophthalmology leaders. OCTOBER 17, 2024 BERWYN, PA – Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., launched LACRIFILL...

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Announces the Launch of LACRIFILL^® Canalicular Gel, a Novel Therapy for Dry Eye

by merzdev | May 29, 2024 | News

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), to Present Data on LACRIFILL^® Canalicular Gel, a Novel Therapy for Dry Eye, at the American Society of Cataract and Refractive Surgery Annual Meeting

by merzdev | Apr 2, 2024 | News

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Appoints Renowned Oculoplastic Surgeon, John P. Fezza, MD to Its Medical Advisory Board

by merzdev | Mar 14, 2024 | News

Amring Pharmaceuticals Inc. announces name change to Nordic Pharma, Inc. under new Nordic Group, B.V. ownership

by merzdev | Mar 4, 2024 | News

Read...

Nordic Group B.V. through its subsidiary Amring Pharmaceuticals Inc., appoints ophthalmology innovator, Eric D. Donnenfeld, MD as Medical Advisory Board Chair

by merzdev | Feb 26, 2024 | News

Read...